Document is current
Any future updates will be listed below
-
Authors
Lasocki, Sigismond
Pène, Frédéric http://orcid.org/0000-0003-3639-3849
Ait-Oufella, Hafid
Aubron, Cécile
Ausset, Sylvain
Buffet, Pierre
Huet, Olivier
Launey, Yoann
Legrand, Matthieu
Lescot, Thomas
Mekontso Dessap, Armand
Piagnerelli, Michael
Quintard, Hervé
Velly, Lionel
Kimmoun, Antoine
Chanques, Gérald
- License Information
-
More Information
Article History
Received: 24 June 2020
Accepted: 30 June 2020
First Online: 22 July 2020
Ethics approval and consent to participate
: Not applicable.
: Not applicable.
: <i>Conflicts of interest of SFAR experts during the 5</i> <i>years preceding the date of validation by the SFAR board</i>:Sylvain Ausset: Research support from Haemonetics™, congress support from Terumo™; Gérald Chanques: Lecturer personally funded by Aspen Medical France™, Orion Pharma™; consulting for Orion Pharma™; Olivier Huet, Yoann Launey, Hervé Quintard, Lionel Velly declare that they have no competing; Sigismond Lasocki: Lecturer personally funded by Pfizer™, Vifor Pharma™, Masimo™; consulting for Pfizer™, Vifor Pharma™; research support from Vifor Pharma™; Matthieu Legrand: Lecturer personally funded by Baxter™ France, Fresenius™; consulting for Novartis™; research support from Sphigotec™; Thomas Lescot: Lecturer personally funded by Baxter™, BBraun™, Fresenius™.<i>Conflicts of interest of SRLF experts during the 5 years preceding the date of validation by the SRLF board</i>:Hafid Ait-Oufella, Cécile Aubron, Armand Mekontso Dessap, Frédéric Pène, Michael Piagnerelli declare that they have no competing interest; Antoine Kimmoun: Lecturer personally funded by Aspen Medical France™, Gilead™, Baxter™, MSD™.<i>Conflicts of interest of associate society experts during the 5</i> <i>years preceding the date of validation by their respective boards</i>:Pierre Buffet declares that he has no competing interests.
